2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

Radiofrequency Catheter Ablation of Ventricular Tachycardia in Patients With Hypertrophic Cardiomyopathy and Apical Aneurysm

Igarashi, M., Nogami, A., Kurosaki, K., Hanaki, Y., Komatsu, Y., Fukamizu, S., Morishima, I., Kaitani, K., Nishiuchi, S., Talib, A. K., et al. (2018) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2017.12.020 · Cited by 78

Apical myectomy for patients with hypertrophic cardiomyopathy and advanced heart failure

Nguyen, A. P., Schaff, H. V., Nishimura, R. A., Geske, J. B., Dearani, J. A., King, K. S., & Ommen, S. R. (2019) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2019.03.088 · Cited by 78

Transvenous Implantable Cardioverter‐Defibrillator (ICD) Lead Performance: A Meta‐Analysis of Observational Studies

Providencia, R. A., Kramer, D. B., Pimenta, D., Babu, G. G., Hatfield, L. A., Ioannou, A., Novak, J., Hauser, R. G., & Lambiase, P. D. (2015) · Journal of the American Heart Association · doi:10.1161/jaha.115.002418 · Cited by 77

The Electrocardiogram as a Diagnostic Tool for Hypertrophic Cardiomyopathy: Revisited

Maron, B. J. (2001) · Annals of Noninvasive Electrocardiology · doi:10.1111/j.1542-474x.2001.tb00118.x · Cited by 76

Interaction of Adverse Disease Related Pathways in Hypertrophic Cardiomyopathy

Rowin, E. J., Maron, M. S., Chan, R. H. M., Hausvater, A., Wang, W., Rastegar, H., & Maron, B. J. (2017) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2017.08.048 · Cited by 76

Risk factors for lethal arrhythmic events in children and adolescents with hypertrophic cardiomyopathy and an implantable defibrillator: An international multicenter study

Balaji, S., DiLorenzo, M. P., Fish, F. A., Etheridge, S. P., Aziz, P. F., Russell, M. W. W., Tisma‐Dupanovic, S., Pflaumer, A., Sreeram, N., Kubuš, P., et al. (2019) · Heart Rhythm · doi:10.1016/j.hrthm.2019.04.040 · Cited by 76

Natural history of genotype positive–phenotype negative patients with hypertrophic cardiomyopathy

Gray, B. R., Ingles, J., & Semsarian, C. (2011) · International Journal of Cardiology · doi:10.1016/j.ijcard.2011.07.095 · Cited by 75

Quantifying Diastolic Function in Hypertrophic Cardiomyopathy

Rakowski, H., & Carasso, S. (2007) · Circulation · doi:10.1161/circulationaha.107.742395 · Cited by 74

Effect of Biventricular Pacing on Symptoms and Cardiac Remodelling in Patients with End-Stage Hypertrophic Cardiomyopathy

Rogers, D. P. S., Marazìa, S., CHOW, A. W. C., Lambiase, P. D., LOWE, M. D., Frenneaux, M. P., McKenna, W. J., & Elliot, P. M. (2008) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2008.03.006 · Cited by 74

Effectiveness and Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation With Hypertrophic Cardiomyopathy

Jung, H., Yang, P., Jang, E., Yu, H. T., Kim, T., Uhm, J., Kim, J., Pak, H., Lee, M., Joung, B., et al. (2018) · CHEST Journal · doi:10.1016/j.chest.2018.11.009 · Cited by 74

Comparison of Maximal Wall Thickness in Hypertrophic Cardiomyopathy Differs Between Magnetic Resonance Imaging and Transthoracic Echocardiography

Bois, J. P., Geske, J. B., Foley, T. A., Ommen, S. R., & Pellikka, P. A. (2016) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2016.11.010 · Cited by 73

Guideline-Based Referral for Septal Reduction Therapy in Obstructive Hypertrophic Cardiomyopathy Is Associated With Excellent Clinical Outcomes

Kimmelstiel, C. D., Zisa, D. C., Kuttab, J. S., Wells, S. B., Udelson, J. E., Wessler, B. S., Rastegar, H., Kapur, N. K., WEINTRAUB, A. R., Maron, B. J., et al. (2019) · Circulation Cardiovascular Interventions · doi:10.1161/circinterventions.118.007673 · Cited by 73

Successful Catheter Ablation of Hemodynamically Unstable Monomorphic Ventricular Tachycardia in a Patient with Hypertrophic Cardiomyopathy and Apical Aneurysm

Lim, K.-K., Maron, B. J., & Knight, B. P. (2008) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2008.01366.x · Cited by 72

Utility of Isoproterenol to Provoke Outflow Tract Gradients in Patients With Hypertrophic Cardiomyopathy

Elesber, A. A., Nishimura, R. A., Rihal, C. S., Ommen, S. R., Schaff, H. V., & Holmes, D. R. (2007) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2007.09.111 · Cited by 72

Comparable effects of oral diltiazem and verapamil in the treatment of hypertrophic cardiomyopathy. Double-blind crossover study.

Toshima, H., Koga, Y., Nagata, H., Toyomasu, K., Itaya, K.-I., & Matoba, T. (1986) · Japanese Heart Journal · doi:10.1536/ihj.27.701 · Cited by 72

Non-invasive assessment of diastolic function in hypertrophic cardiomyopathy on and off beta adrenergic blocking drugs.

Alvares, R. F., & Goodwin, J. F. (1982) · Heart · doi:10.1136/hrt.48.3.204 · Cited by 71

High Prevalence of Abnormal Nocturnal Oximetry in Patients With Hypertrophic Cardiomyopathy

Eleid, M. F., Konečný, T., Orban, M., Sengupta, P. P., Somers, V. K., Parish, J. M., Mookadam, F., Brady, P. A., Sullivan, B. L., Khandheria, B. K., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.07.030 · Cited by 70

How to Image Hypertrophic Cardiomyopathy

Maron, M. S., Rowin, E. J., & Maron, B. J. (2017) · Circulation: Cardiovascular Imaging · doi:10.1161/circimaging.116.005372 · Cited by 70

Impact of intraoperative transesophageal echocardiography in the surgical management of hypertrophic cardiomyopathy

Ommen, S. R., Park, S. H., Click, R. L., Freeman, W. K., Schaff, H. V., & Tajik, A. J. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)02694-2 · Cited by 69

Sudden death in hypertrophic cardiomyopathy: old risk factors re-assessed in a new model of maximalized follow-up

Dimitrow, P. P., Chojnowska, L., Rudziński, T., Piotrowski, W., Ziółkowska, L., Wojtarowicz, A., Wycisk, A., Dąbrowska-Kugacka, A., Nowalany-Kozielska, E., Sobkowicz, B., et al. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq308 · Cited by 69

Subcutaneous Implantable Cardioverter Defibrillator in Patients With Hypertrophic Cardiomyopathy: An Initial Experience

Weinstock, J., Bader, Y. H., Maron, M. S., Rowin, E. J., & Link, M. S. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.115.002488 · Cited by 69

Cardiac Transplantation in Patients With Hypertrophic Cardiomyopathy

Kato, T., Takayama, H., Yoshizawa, S., Marboe, C. C., Schulze, P. C., FARR, M. A., Naka, Y., MANCINI, D. M., & Maurer, M. S. (2012) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2012.04.030 · Cited by 67

Does Sport Participation Worsen the Clinical Course of Hypertrophic Cardiomyopathy?

Pelliccia, A., Lemme, E., Maestrini, V., Paolo, F. M. D., Pisicchio, C., Gioia, G. D., & Caselli, S. (2018) · Circulation · doi:10.1161/circulationaha.117.031725 · Cited by 67

Papillary Muscle Insertion Directly into the Anterior Mitral Leaflet in Hypertrophic Cardiomyopathy, Its Identification and Cause of Outflow Obstruction by Cardiac Magnetic Resonance Imaging, and Its Surgical Management

Rowin, E. J., Maron, B. J., Lesser, J. R., Rastegar, H., & Maron, M. S. (2013) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2013.01.340 · Cited by 66

Heart Failure Progression in Hypertrophic Cardiomyopathy – Possible Insights From Cardiopulmonary Exercise Testing –

Magrì, D., Re, F., Limongelli, G., Agostoni, P., Zachara, E., Correale, M., Mastromarino, V., Santolamazza, C., Casenghi, M., Pacileo, G., et al. (2016) · Circulation Journal · doi:10.1253/circj.cj-16-0432 · Cited by 65

Determinants for Clinical Diagnosis of Hypertrophic Cardiomyopathy

Adabağ, S., Kuskowski, M. A., & Maron, B. J. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2006.07.029 · Cited by 64

Mexiletine as an Adjunctive Therapy to Amiodarone Reduces the Frequency of Ventricular Tachyarrhythmia Events in Patients With an Implantable Defibrillator

Gao, D., Herendael, H. V., Alshengeiti, L., Dorian, P., Mangat, I., Korley, V. J., Ahmad, K., Golovchiner, G., Aves, T., & Pintér, A. (2013) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e31829651fe · Cited by 64

A validation study of the European Society of Cardiology guidelines for risk stratification of sudden cardiac death in childhood hypertrophic cardiomyopathy

Norrish, G., Ding, T., Field, E., McLEOD, K. A., Ilina, M. V., Stuart, G., Bhole, V., Uzun, O., Brown, E., Daubeney, P. E. F., et al. (2019) · EP Europace · doi:10.1093/europace/euz118 · Cited by 63

Comparison of Clinical Presentation, Left Ventricular Morphology, Hemodynamics, and Exercise Tolerance in Obese Versus Nonobese Patients With Hypertrophic Cardiomyopathy

Canepa, M., Sorensen, L. L., Pozios, I., Dimaano, V. L. J., Luo, H.-C., Pinheiro, A. C., Strait, J. B., Brunelli, C., Abraham, M. R., Ferrucci, L., et al. (2013) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2013.05.070 · Cited by 62

Clinical Course and Significance of Hypertrophic Cardiomyopathy Without Left Ventricular Hypertrophy

Maurizi, N., Michels, M., Rowin, E. J., Semsarian, C., Girolami, F., Tomberli, B., Cecchi, F., Maron, M. S., Olivotto, I., & Maron, B. J. (2019) · Circulation · doi:10.1161/circulationaha.118.037264 · Cited by 62

Effect of propranolol on left ventricular relaxation in hypertrophic cardiomyopathy: An echographic study

Bourmayan, C., Razavi, A., Fournier, C., Dussaule, J., Baragan, J., Gerbaux, A., & Gay, J. (1985) · American Heart Journal · doi:10.1016/0002-8703(85)90357-6 · Cited by 61

Impact of Advanced Therapies for Improving Survival to Heart Transplant in Patients with Hypertrophic Cardiomyopathy

Rowin, E. J., Maron, B. J., Abt, P., Kiernan, M. S., Vest, A. R., Costantino, F., Maron, M. S., & DeNofrio, D. D. (2018) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2017.12.044 · Cited by 61

Interactions Between Sleep Disordered Breathing and Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy

Konečný, T., Brady, P. A., Orban, M., Lin, G., Pressman, G. S., Lehár, F., Kára, T., Gersh, B. J., Tajik, A. J., Ommen, S. R., et al. (2010) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2010.01.023 · Cited by 60

Apical Hypertrophic Cardiomyopathy: Prevalence and Correlates of Apical Outpouching

Binder, J. S., Jost, C. H. A., Klarich, K. W., Connolly, H. M., Tajik, A. J., Scott, C. G., Julsrud, P. R., Ehrsam, J.-E., Bailey, K. R., & Ommen, S. R. (2011) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2011.03.002 · Cited by 60

Left ventricular wall thickness in patients with hypertrophic cardiomyopathy: a comparison between cardiac magnetic resonance imaging and echocardiography

Corona‐Villalobos, C. P., Sorensen, L. L., Pozios, I., Chu, L. C. H., Eng, J., Abraham, M. R., Abraham, T. P., Kamel, I. R., & Zimmerman, S. L. (2016) · International journal of cardiac imaging · doi:10.1007/s10554-016-0858-4 · Cited by 60

Reduced Risk for Inappropriate Implantable Cardioverter-Defibrillator Shocks With Dual-Chamber Therapy Compared With Single-Chamber Therapy

Kolb, C., Sturmer, M., Sick, P. B., Reif, S., Davy, J. M., Molon, G., SCHWAB, J. O., Mantovani, G., Dan, D., Lennerz, C., et al. (2014) · JACC Heart Failure · doi:10.1016/j.jchf.2014.05.015 · Cited by 60

Clinical Significance of Late Gadolinium Enhancement in Patients <20 Years of Age With Hypertrophic Cardiomyopathy

Smith, B. M., Dorfman, A. L., Yu, S., Russell, M. W. W., Agarwal, P., Mahani, M. G., & Lu, J. C. (2014) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2013.12.034 · Cited by 59

Intraprocedural myocardial contrast echocardiography as a routine procedure in percutaneous transluminal septal myocardial ablation: Detection of threatening myocardial necrosis distant from the septal target area

Faber, L., Seggewiß, H., Ziemssen, P., & Gleichmann, U. (1999) · Catheterization and Cardiovascular Interventions · doi:10.1002/(sici)1522-726x(199908)47:4 · Cited by 59

Prediction of sudden death risk in obstructive hypertrophic cardiomyopathy: Potential for refinement of current criteria

Desai, M. Y., Smedira, N. G., Dhillon, A. S., Masri, A., Wazni, O. M., Kanj, M., Sato, K., Thamilarasan, M., Popović, Z., & Lever, H. M. (2018) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2018.03.150 · Cited by 59

Outcomes of nonpharmacologic treatment of atrial fibrillation in patients with hypertrophic cardiomyopathy

Bassiouny, M., Lindsay, B. D., Lever, H. M., Saliba, W. I., Klein, A. L., Banna, M., Abraham, J. M., Shao, M., Rickard, J., Kanj, M. H., et al. (2015) · Heart Rhythm · doi:10.1016/j.hrthm.2015.03.042 · Cited by 58

Incidence of Device-Detected Atrial Fibrillation and Long-Term Outcomes in Patients With Hypertrophic Cardiomyopathy

van Velzen, H. G., Theuns, D. A. M. J., Yap, S., Michels, M., & Schinkel, A. F. L. (2016) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2016.08.092 · Cited by 58

Direct oral anticoagulants in patients with hypertrophic cardiomyopathy and atrial fibrillation

Domínguez, F., Climent, V. E., Zorio, E., Ripoll‐Vera, T., Salazar‐Mendiguchía, J., García‐Pinilla, J. M., Urbano-Moral, J. Á., Fernández, X., López-Cuenca, D., Ajo, R., et al. (2017) · International Journal of Cardiology · doi:10.1016/j.ijcard.2017.08.010 · Cited by 58

Clinical Spectrum and Management Implications of Left Ventricular Outflow Obstruction With Mild Ventricular Septal Thickness in Hypertrophic Cardiomyopathy

Rowin, E. J., Maron, B. J., Chokshi, A. D., Kannappan, M., Arkun, K., Wang, W., Rastegar, H., & Maron, M. S. (2018) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2018.06.055 · Cited by 58

Intraoperative Two- and Three-Dimensional Transesophageal Echocardiography in Combined Myectomy-Mitral Operations for Hypertrophic Cardiomyopathy

Nampiaparampil, R. G., Swistel, D. G., Schlame, M., Sarić, M., & Sherrid, M. V. (2018) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2017.11.016 · Cited by 57

Changes in the left ventricular outflow tract after transcoronary ablation of septal hypertrophy (TASH) for hypertrophic obstructive cardiomyopathy as assessed by transoesophageal echocardiography and by measuring myocardial glucose utilization and perfusion

Kuhn, H. J. (1999) · European Heart Journal · doi:10.1053/euhj.1999.1692 · Cited by 56

Ventricular Tachyarrhythmias in Patients With Hypertrophic Cardiomyopathy and Defibrillators: Triggers, Treatment, and Implications

Link, M. S., Bockstall, K. E., Weinstock, J., Alsheikh-Ali, A. A. A., Semsarian, C., Estes, N. A. M., Spirito, P., Haas, T. S., Rowin, E. J., Maron, M. S., et al. (2017) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.13194 · Cited by 56

Determinants of Reverse Remodeling of the Left Atrium After Transaortic Myectomy

Nguyen, A. P., Schaff, H. V., Nishimura, R. A., Dearani, J. A., Geske, J. B., Lahr, B. D., & Ommen, S. R. (2018) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2018.03.039 · Cited by 56

Dual- vs. single-chamber defibrillators for primary prevention of sudden cardiac death: long-term follow-up of the Défibrillateur Automatique Implantable—Prévention Primaire registry

Defaye, P., Bovéda, S., Klug, D., Beganton, F., Piot, O., Narayanan, K., Perier, M., Gras, D., Fauchier, L., Bordachar, P., et al. (2017) · EP Europace · doi:10.1093/europace/euw230 · Cited by 55

Septal Myectomy in Hypertrophic Cardiomyopathy: National Outcomes of Concomitant Mitral Surgery

Holst, K. A., Hanson, K. T., Ommen, S. R., Nishimura, R. A., Habermann, E. B., & Schaff, H. V. (2019) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2018.07.022 · Cited by 55

Long-Term Follow-Up of Children and Adolescents Diagnosed with Hypertrophic Cardiomyopathy: Risk Factors for Adverse Arrhythmic Events

Moak, J. P., Leifer, E., Tripodi, D. J., MOHIDDIN, S. A., & Fananapazir, L. (2011) · Pediatric Cardiology · doi:10.1007/s00246-011-9967-y · Cited by 54

High Incidence of De Novo and Subclinical Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy and Cardiac Rhythm Management Device

Wilke, I., Witzel, K., Münch, J., Pecha, S., Blankenberg, S., Reichenspurner, H. C., Willems, S., Patten, M., & Aydın, A. (2016) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.12982 · Cited by 54

Stroke and Bleeding Risks in NOAC- and Warfarin-Treated Patients With Hypertrophic Cardiomyopathy and Atrial Fibrillation

Noseworthy, P. A., Yao, X., Shah, N. D., & Gersh, B. J. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.04.026 · Cited by 53

Clinical genetic testing in pediatric cardiomyopathy: Is bigger better?

Ouellette, A. C., Mathew, J., Manickaraj, A. K., Manase, G., Zahavich, L. A., Wilson, J., George, K., Benson, L. N., Bowdin, S. C., & Mital, S. R. (2017) · Clinical Genetics · doi:10.1111/cge.13024 · Cited by 53

Dofetilide Reduces the Frequency of Ventricular Arrhythmias and Implantable Cardioverter Defibrillator Therapies

Baquero, G. A., Banchs, J. E., DePalma, S. M., Young, S. K., Penny-Peterson, E., Samii, S. M., Wolbrette, D. L., Naccarelli, G. V., & Gonzalez, M. D. (2011) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2011.02183.x · Cited by 52

Hypertrophic cardiomyopathy in cardiac CT: a validation study on the detection of intramyocardial fibrosis in consecutive patients

Langer, C., Lutz, M., Eden, M., Lüdde, M., Hohnhorst, M., Gierloff, C., Both, M., Burchert, W., Faber, L., Horstkotte, D., et al. (2014) · International journal of cardiac imaging · doi:10.1007/s10554-013-0358-8 · Cited by 52

Hemodynamic effects of verapamil in children and adolescents with hypertrophic cardiomyopathy.

Spicer, R., Rocchini, A. P., Crowley, D., Vasiliades, J., & Rosenthal, A. (1983) · Circulation · doi:10.1161/01.cir.67.2.413 · Cited by 52

Clinical significance of left ventricular apical aneurysms in hypertrophic cardiomyopathy patients: The role of diagnostic electrocardiography

Ichida, M., Nishimura, Y., & Kario, K. (2014) · Journal of Cardiology · doi:10.1016/j.jjcc.2014.02.011 · Cited by 52

Pregnancy in women with hypertrophic cardiomyopathy

Pieper, P. G., & Walker, F. (2012) · Netherlands Heart Journal · doi:10.1007/s12471-012-0358-7 · Cited by 52

Quantification of myocardial delayed enhancement and wall thickness in hypertrophic cardiomyopathy: Multidetector computed tomography versus magnetic resonance imaging

Zhao, L., Ma, X., Feuchtner, G. M., Zhang, C., & Fan, Z. (2014) · European Journal of Radiology · doi:10.1016/j.ejrad.2014.05.035 · Cited by 51

Occurrence and Natural History of Clinically Silent Episodes of Atrial Fibrillation in Hypertrophic Cardiomyopathy

Rowin, E. J., Orfanos, A., Estes, N. A. M., Wang, W., Link, M. S., Maron, M. S., & Maron, B. J. (2017) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2017.02.040 · Cited by 51

Accuracy of the ECG for differential diagnosis between hypertrophic cardiomyopathy and athlete’s heart: comparison between the European Society of Cardiology (2010) and International (2017) criteria

Zorzi, A., Calore, C., Vio, R., Pelliccia, A., & Corrado, D. (2017) · British Journal of Sports Medicine · doi:10.1136/bjsports-2016-097438 · Cited by 51

Asymmetric septal hypertrophy in patients with severe aortic stenosis: The usefulness of associated septal myectomy

Tommaso, L. D., Stassano, P., Mannacio, V. A., Russolillo, V., Monaco, M., Pinna, G. B., & Vosa, C. (2012) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2011.10.096 · Cited by 50

Imaging Phenotype Versus Genotype in Hypertrophic Cardiomyopathy

Desai, M. Y., Ommen, S. R., McKenna, W. J., Lever, H. M., & Elliot, P. M. (2011) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.110.957936 · Cited by 50

Mitral valve and papillary muscle abnormalities in hypertrophic obstructive cardiomyopathy

Teo, E. P., Teoh, J. G., & Hung, J. (2015) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000200 · Cited by 50

Standardized Goal-Directed Valsalva Maneuver for Assessment of Inducible Left Ventricular Outflow Tract Obstruction in Hypertrophic Cardiomyopathy

Kumar, S., Ness, G. V., Bender, A. B., Yadava, M., Minnier, J., Ravi, S., McGrath, L. B., Song, H. K., & Heitner, S. B. (2018) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2018.01.022 · Cited by 49

Pregnancy in women with a cardiomyopathy: Outcomes and predictors from a retrospective cohort

Billebeau, G., Etienne, M., Cheikh-Khelifa, R., Vauthier-Brouzes, D., Gandjbakhch, E., Isnard, R., Nizard, J., Michel Komajda, N., Dommergues, M., & Charron, P. (2017) · Archives of cardiovascular diseases · doi:10.1016/j.acvd.2017.05.010 · Cited by 49

Impact of Septal Reduction on Left Atrial Size and Diastole in Hypertrophic Cardiomyopathy

Finocchiaro, G., Haddad, F., Kobayashi, Y., Lee, D. P., Pavlović, A., Schnittger, I., Sinagra, G., Magavern, E. F., MYERS, J. N., Froelicher, V. F., et al. (2016) · Echocardiography · doi:10.1111/echo.13158 · Cited by 48

Comparison of Valsalva Maneuver, Amyl Nitrite, and Exercise Echocardiography to Demonstrate Latent Left Ventricular Outflow Obstruction in Hypertrophic Cardiomyopathy

Ayoub, C., Geske, J. B., Larsen, C., Scott, C. G., Klarich, K. W., & Pellikka, P. A. (2017) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2017.08.047 · Cited by 48

Centrifugal Continuous-Flow Left Ventricular Assist Device in Patients With Hypertrophic Cardiomyopathy

Muthiah, K., Phan, J. A.-K., Robson, D., Macdonald, P. S., KEOGH, A. M., Kotlyar, E., Granger, E. K., Dhital, K. K., Spratt, P. M., Jansz, P. C., et al. (2013) · ASAIO Journal · doi:10.1097/mat.0b013e318286018d · Cited by 47

Safety, Side Effects and Relative Efficacy of Medications for Rhythm Control of Atrial Fibrillation in Hypertrophic Cardiomyopathy

Miller, C. A. S., Maron, M. S., Estes, N. A. M., Price, L. L., Rowin, E. J., Maron, B. J., & Link, M. S. (2019) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2019.02.051 · Cited by 47

Cardiac resynchronization therapy in patients with end-stage hypertrophic cardiomyopathy

Killu, A. M., Park, J.-Y., Sara, J. D. S., Hodge, D. O., Gersh, B. J., Nishimura, R. A., Asirvatham, S. J., & McLeod, C. J. (2016) · EP Europace · doi:10.1093/europace/euw327 · Cited by 45

Role of exercise electrocardiogram to screen for T-wave oversensing after implantation of subcutaneous implantable cardioverter-defibrillator

Afzal, M. R., Evenson, C. M., Badin, A. G., Patel, D., Godara, H., Essandoh, M. K., Okabe, T., Tyler, J. D., Houmsse, M., Augostini, R. S., et al. (2017) · Heart Rhythm · doi:10.1016/j.hrthm.2017.06.022 · Cited by 45

Apical Hypertrophic Cardiomyopathy: Echocardiographic Diagnosis with the Use of Intravenous Contrast Image Enhancement

Thanigaraj, S., & Pérez, J. E. (2000) · Journal of the American Society of Echocardiography · doi:10.1016/s0894-7317(00)90026-9 · Cited by 44

Disease Severity and Exercise Testing Reduce Subcutaneous Implantable Cardioverter-Defibrillator Left Sternal ECG Screening Success in Hypertrophic Cardiomyopathy

Srinivasan, N. T., Patel, K. H. K., Qamar, K., Taylor, A., Bacà, M., Providencia, R. A., Tome, M., Elliot, P. M., & Lambiase, P. D. (2017) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.117.004801 · Cited by 43

Long-term follow-up of subcutaneous ICD systems in patients with hypertrophic cardiomyopathy: a single-center experience

Frommeyer, G., Dechering, D. G., Zumhagen, S., Löher, A., Köbe, J., Eckardt, L., & Reinke, F. (2015) · Clinical Research in Cardiology · doi:10.1007/s00392-015-0901-9 · Cited by 41

Upright treadmill vs. semi-supine bicycle exercise echocardiography to provoke obstruction in symptomatic hypertrophic cardiomyopathy: a pilot study

Réant, P., Dufour, M., Peyrou, J., Reynaud, A. J., Rooryck, C., Dijos, M., Vincent, C., Cornolle, C., Roudaut, R., & Lafitte, S. (2016) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jew313 · Cited by 41

The Natural History of Nonobstructive Hypertrophic Cardiomyopathy

Hebl, V. B., Miranda, W. R., Ong, K. C., Hodge, D. O., Bos, J. M., Gentile, F., Klarich, K. W., Nishimura, R. A., Ackerman, M. J., Gersh, B. J., et al. (2016) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2016.01.002 · Cited by 39

Return-to-Play for Athletes With Genetic Heart Diseases

Turkowski, K. L., Bos, J. M., Ackerman, N. C., Rohatgi, R. K., & Ackerman, M. J. (2018) · Circulation · doi:10.1161/circulationaha.117.031306 · Cited by 39

Implanted Defibrillators in Young Hypertrophic Cardiomyopathy Patients: A Multicenter Study

Kamp, A. N., Bergen, N. H. V., Henrikson, C. A., Makhoul, M., Saarel, E. V., LaPage, M. J., Russell, M. W. W., Strieper, M. J., Yu, S., Dick, M., et al. (2013) · Pediatric Cardiology · doi:10.1007/s00246-013-0676-6 · Cited by 38

Concomitant ablation for atrial fibrillation during septal myectomy in patients with hypertrophic obstructive cardiomyopathy

Bogachev-Prokophiev, A. V., Afanasyev, A. V., Иванович, Ж. С., Pivkin, A. N., Фоменко, М. С., Махарамович, Ш. Р., & Karaskov, A. M. (2017) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2017.08.063 · Cited by 38

Comparison of Inappropriate Shocks and Other Health Outcomes Between Single‐ and Dual‐Chamber Implantable Cardioverter‐Defibrillators for Primary Prevention of Sudden Cardiac Death: Results From the Cardiovascular Research Network Longitudinal Study of Implantable Cardioverter‐Defibrillators

Peterson, P. N., Greenlee, R. T., Go, A. S., Magid, D. J., Cassidy‐Bushrow, A. E., Garcia-Montilla, R. J., Glenn, K. A., Gurwitz, J. H., Hammill, S. C., Hayes, J., et al. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.117.006937 · Cited by 38

Assessment of coronary artery disease risk in 5463 patients undergoing cardiac surgery: When is preoperative coronary angiography necessary?

Thalji, N. M., Suri, R. M., Daly, R. C., Dearani, J. A., Burkhart, H. M., Park, S. J., Greason, K. L., Joyce, L. D., Stulak, J. M., Huebner, M., et al. (2013) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2013.06.046 · Cited by 37

Defibrillation Thresholds in Hypertrophic Cardiomyopathy

Quin, E. M., Cuoco, F. A., Forcina, M. S., Coker, J. B., Yoe, R. H., Spencer, W. H., Fernandes, V. L. C., Nielsen, C. D., Sturdivant, J. L., Leman, R. B., et al. (2010) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2010.01943.x · Cited by 37

Effects of diltiazem on myocardial perfusion abnormalities during exercise in patients with hypertrophic cardiomyopathy

Sugihara, H., Taniguchi, Y., Ito, K., Terada, K., Matsumoto, K., Kinoshita, N., Azuma, A., Ushuima, Y., Maeda, T., & Nakagawa, M. (1998) · Annals of Nuclear Medicine · doi:10.1007/bf03164924 · Cited by 37

Antihypertensive Therapy in Hypertrophic Cardiomyopathy

Argulian, E., Messerli, F. H., Aziz, E. F., Winson, G., Agarwal, V., Kaddaha, F., Kim, B., & Sherrid, M. V. (2013) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2012.12.026 · Cited by 37

Safety and efficacy of transvenous high-voltage implantable cardioverter-defibrillator leads in high-risk hypertrophic cardiomyopathy patients

Hauser, R. G., Maron, B. J., Marine, J. E., Lampert, R. J., Kadish, A. H., Winters, S. L., Scher, D. L., Biria, M., & Kalia, A. (2008) · Heart Rhythm · doi:10.1016/j.hrthm.2008.08.021 · Cited by 36

Comparison of Valsalva manoeuvre and exercise in echocardiographic evaluation of left ventricular outflow tract obstruction in hypertrophic cardiomyopathy

Jensen, M. K., Havndrup, O., Pecini, R., Dalsgaard, M., Hassager, C., Helqvist, S., Kelbæk, H., Jørgensen, E. O., Køber, L., & Bundgaard, H. (2010) · European Journal of Echocardiography · doi:10.1093/ejechocard/jeq063 · Cited by 36

Shared decision-making in HCM

Maron, B. J., Nishimura, R. A., & Maron, M. S. (2017) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2017.6 · Cited by 36

Significance of Pulmonary Hypertension in Hypertrophic Cardiomyopathy

Mitra, A., Ghosh, R. K., Bandyopadhyay, D., Ghosh, G. C., Kalra, A., & Lavie, C. J. (2018) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2018.10.002 · Cited by 34

Penetrance of Hypertrophic Cardiomyopathy in Children Who Are Mutation Positive

Vermeer, A. M. C., Clur, S. B., Blom, N. A., Wilde, A. A. M., & Christiaans, I. (2017) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2017.03.033 · Cited by 33

Obstructive sleep apnea is associated with nonsustained ventricular tachycardia in patients with hypertrophic obstructive cardiomyopathy

Wang, S., Cui, H., Song, C., Zhu, C., Wu, R., Meng, L., Yu, Q., Huang, X., & Wang, S. (2019) · Heart Rhythm · doi:10.1016/j.hrthm.2018.12.017 · Cited by 33

Mid-term outcomes of concomitant surgical ablation of atrial fibrillation in patients undergoing cardiac surgery for hypertrophic cardiomyopathy†

Lapenna, E., Pozzoli, A., Bonis, M. D., Canna, G. L., Nisi, T., Nascimbene, S., Vicentini, L., Sanzo, S. D., Forno, B. D., Schiavi, D., et al. (2017) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezx017 · Cited by 32

Cardiac Resynchronization Therapy for End-Stage Hypertrophic Cardiomyopathy

Cappelli, F., Morini, S., Pieragnoli, P., Targetti, M., Stefàno, P., Marchionni, N., & Olivotto, I. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.11.040 · Cited by 32

Dofetilide for suppression of atrial fibrillation in hypertrophic cardiomyopathy: A case series and literature review

Moore, J. C., Trager, L. E., Anzia, L. E., Saliba, W. I., Bassiouny, M., Bhargava, M., Chung, M. K., Desai, M. Y., Garberich, R., Lever, H. M., et al. (2018) · Pacing and Clinical Electrophysiology · doi:10.1111/pace.13310 · Cited by 31

Doppler Evaluation of the Descending Aorta in Patients with Hypertrophic Cardiomyopathy: Potential for Assessing the Functional Significance of Outflow Tract Gradients and for Optimizing Pacemaker Function

Mickelsen, S. R., Bathina, M. N., Hsu, P., Holmes, J., & Kusumoto, F. M. (2004) · Journal of Interventional Cardiac Electrophysiology · doi:10.1023/b:jice.0000035929.84238.2f · Cited by 30

Predictors of Exercise Capacity in Patients with Hypertrophic Obstructive Cardiomyopathy

Smith, J. R., Medina‐Inojosa, J. R., Layrisse, V., Ommen, S. R., & Olson, T. P. (2018) · Journal of Clinical Medicine · doi:10.3390/jcm7110447 · Cited by 30

Hypertrophic cardiomyopathy in pediatric patients: effect of verapamil on regional and global left ventricular diastolic function.

Pacileo, G., De Cristofaro, M., Russo, M. G., Sarubbi, B., Pisacane, C., & Calabrò, R. (2000) · PubMed · Cited by 29

Remission of recurrent gastrointestinal bleeding after septal reduction therapy in patients with hypertrophic obstructive cardiomyopathy‐associated acquired von Willebrand syndrome

Blackshear, J. L., Stark, M. E., Agnew, R. C., Moussa, I. D., Safford, R. E., Shapiro, B. P., Waldo, O. A., & Chen, D. (2014) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12780 · Cited by 28

Evaluation of apical pouches in hypertrophic cardiomyopathy using cardiac MRI

Kebed, K. Y., Adham, R. I. A., Bishu, K. G., Askew, J. W., Klarich, K. W., Oh, J. K., Julsrud, P. R., Foley, T. A., Glockner, J. F., Nishimura, R. A., et al. (2014) · International journal of cardiac imaging · doi:10.1007/s10554-013-0355-y · Cited by 28

Effects of verapamil on haemodynamic function and myocardial metabolism in patients with hypertrophic cardiomyopathy.

Wilmshurst, P. T., Thompson, D. S., Juul, S. M., Jenkins, B. S., & Webb-Peploe, M. M. (1986) · Heart · doi:10.1136/hrt.56.6.544 · Cited by 28

Long-Term Outcomes of Orthotopic Heart Transplantation for Hypertrophic Cardiomyopathy

Lee, M. S., Zimmer, R. J., & KOBASHIGAWA, J. A. (2014) · Transplantation Proceedings · doi:10.1016/j.transproceed.2013.12.052 · Cited by 27

Decreased Exercise Capacity and Sleep-Disordered Breathing in Patients With Hypertrophic Cardiomyopathy

Konečný, T., Geske, J. B., Ludka, O., Orban, M., Brady, P. A., Abudiab, M. M., Albuquerque, F. N., Placek, A., Kára, T., Sahakyan, K., et al. (2015) · CHEST Journal · doi:10.1378/chest.14-1498 · Cited by 26

Risk of Cardiomyopathy in Younger Persons With a Family History of Death from Cardiomyopathy

Ranthe, M. F., Carstensen, L., Øyen, N., Jensen, M. K., Raja, A. A., Wohlfahrt, J., Melbye, M., Bundgaard, H., & Boyd, H. A. (2015) · Circulation · doi:10.1161/circulationaha.114.013478 · Cited by 25

Prognostic Implications of Defibrillation Threshold Testing in Patients With Hypertrophic Cardiomyopathy

Francia, P., Adduci, C., Semprini, L., Palano, F., Santini, D., Musumeci, B., Santolamazza, C., Volpe, M., & Autore, C. (2016) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.13121 · Cited by 24

Usefulness of Von Willebrand Factor Activity Indexes to Predict Therapeutic Response in Hypertrophic Cardiomyopathy

Blackshear, J. L., Kusumoto, H., Safford, R. E., Wysokinska, E. M., Thomas, C. S., Waldo, O. A., Stark, M. E., Shapiro, B. P., Ung, S., Moussa, I. D., et al. (2015) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2015.11.016 · Cited by 22

Hemodynamic changes in systolic and diastolic function during isoproterenol challenge predicts symptomatic response to myectomy in hypertrophic cardiomyopathy with labile obstruction

Prasad, M., Geske, J. B., Sorajja, P., Ommen, S. R., Schaff, H. V., Gersh, B. J., & Nishimura, R. A. (2016) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.26472 · Cited by 22

Clinical outcome of cardiac resynchronization therapy in dilated-phase hypertrophic cardiomyopathy.

Gu, M., Jin, H., Hua, W., Fan, X., Niu, H., Tian, T., Ding, L., Wang, J., Xue, C., & Zhang, S. (2017) · Europe PMC (PubMed Central) · doi:10.11909/j.issn.1671-5411.2017.04.002 · Cited by 22

0203: Pregnancy in women with a cardiomyopathy: outcomes and predictors from a retrospective cohort

Billebeau, G., Etienne, M., Cheikh-Khelifa, R., Vauthier-Brouzes, D., Gandjbakhch, E., Isnard, R., Nizard, J., Michel Komajda, N., Dommergues, M., & Charron, P. (2016) · Archives of Cardiovascular Diseases Supplements · doi:10.1016/s1878-6480(16)30103-3 · Cited by 21

Benefit of Cardiac Resynchronization Therapy in End-Stage Nonobstructive Hypertrophic Cardiomyopathy

Rowin, E. J., Mohanty, S., Madias, C. A., Maron, B. J., & Maron, M. S. (2019) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2018.08.018 · Cited by 21

Implantable cardioverter–defibrillator therapy in hypertrophic cardiomyopathy: A SIMPLE substudy

Vámos, M., Healey, J. S., Wang, J., Connolly, S. J., Mabo, P., van Erven, L., Kautzner, J., Glikson, M., Neuzner, J., O’Hara, G. E., et al. (2017) · Heart Rhythm · doi:10.1016/j.hrthm.2017.11.020 · Cited by 20

Wilkoff BL, et al. 2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing

(2017) · EP Europace · doi:10.1093/europace/euw260 · Cited by 19

Efficiencies and Complications of Dual Chamber versus Single Chamber Implantable Cardioverter Defibrillators in Secondary Sudden Cardiac Death Prevention: A Meta-analysis

Hu, Z., Zhang, J., Xu, Z.-T., Gao, X., Zhang, H., Pan, C., & Chen, S. (2015) · Heart Lung and Circulation · doi:10.1016/j.hlc.2015.07.008 · Cited by 18

Role of Imaging in the Evaluation of Patients at Risk for Sudden Cardiac Death

Nagueh, S. F., & Zoghbi, W. A. (2015) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2015.04.006 · Cited by 17

Pathogenicity of Hypertrophic Cardiomyopathy Variants

Ingles, J., Burns, C., & Funke, B. (2017) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.117.001916 · Cited by 16

Contrast-Enhanced Echocardiography Has the Greatest Impact in Patients with Reduced Ejection Fractions

Zhao, H., O’Quinn, R. P., Ambrose, M., Jagasia, D. H., Ky, B., Wald, J. W., Ferrari, V. A., Kirkpatrick, J. N., & Han, Y. (2017) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2017.09.003 · Cited by 16

Heart muscle disease management in aircrew

D’Arcy, J. L., Manen, O., Davenport, E. D., Syburra, T., Rienks, R., Guettler, N. J., Bron, D., Gray, G. W., & Nicol, E. D. (2018) · Heart · doi:10.1136/heartjnl-2018-313058 · Cited by 15

Single-Coil Defibrillator Leads Yield Satisfactory Defibrillation Safety Margin in Hypertrophic Cardiomyopathy

Okamura, H., Friedman, P. A., Inoue, Y. Y., Noda, T., Aiba, T., Yasuda, S., Ogawa, H., Kamakura, S., KUSANO, K. F., & Espinosa, R. E. (2016) · Circulation Journal · doi:10.1253/circj.cj-16-0428 · Cited by 14

A Control Theory-Based Pilot Intervention toIncrease Physical Activity in Patients WithHypertrophic Cardiomyopathy

Sweeting, J., Ingles, J., Ball, K., & Semsarian, C. (2018) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2018.05.023 · Cited by 14

Global burden of atrial fibrillation/atrial flutter and its attributable risk factors from 1990 to 2021

Cheng, S., He, J., Han, Y., Han, S., Li, P., Liao, H., & Guo, J. (2024) · EP Europace · doi:10.1093/europace/euae195 · Cited by 285

Percutaneous Intramyocardial Septal Radiofrequency Ablation in Patients With Drug-Refractory Hypertrophic Obstructive Cardiomyopathy

Zhou, M., Ta, S., Hahn, R. T., Hsi, D. H., Leon, M. B., Hu, R., Zhang, J., Zuo, L., Li, J., Wang, J., et al. (2022) · JAMA Cardiology · doi:10.1001/jamacardio.2022.0259 · Cited by 107

Diagnostic and prognostic role of late gadolinium enhancement in cardiomyopathies

Aquaro, G. D., Gori, C. D., Faggioni, L., Parisella, M. L., Cioni, D., Lencioni, R. A., & Neri, E. (2023) · European Heart Journal Supplements · doi:10.1093/eurheartjsupp/suad015 · Cited by 106

Arrhythmias as Presentation of Genetic Cardiomyopathy

Laws, J. L., Lancaster, M. C., Shoemaker, M. B., Stevenson, W. G., Hung, R. R., Wells, Q. S., Brinkley, D. M., Hughes, S. G., Anderson, K. C., Roden, D. M., et al. (2022) · Circulation Research · doi:10.1161/circresaha.122.319835 · Cited by 92

Friedreich Ataxia: Multidisciplinary Clinical Care

Lynch, D. R., Schadt, K. A., Kichula, E. A., McCormack, S. E., & Lin, K. Y. (2021) · Journal of Multidisciplinary Healthcare · doi:10.2147/jmdh.s292945 · Cited by 73

2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy

Ommen, S. R., Mital, S., Burke, M. A., Day, S. M., Deswal, A., Elliott, P., Evanovich, L. L., Hung, J., Joglar, J. A., Kantor, P., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.08.045 · Cited by 643

2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines

Ommen, S. R., Ho, C. Y., Asif, I. M., Balaji, S., Burke, M. A., Day, S. M., Dearani, J. A., Epps, K. C., Evanovich, L., Ferrari, V. A., et al. (2024) · Circulation · doi:10.1161/cir.0000000000001250 · Cited by 807

The Wait is Over: The 2020 American Heart Association/American College of Cardiology (AHA/ACC) Hypertrophic Cardiomyopathy Guidelines Have Arrived

Semsarian, C., & Davis, L. (2021) · Heart Lung and Circulation · doi:10.1016/j.hlc.2021.02.002 · Cited by 1

Hypertrophic cardiomyopathy: a practical approach to guideline directed management

Ommen, S. R., & Semsarian, C. (2021) · The Lancet · doi:10.1016/s0140-6736(21)01205-8 · Cited by 92

2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy

Ommen, S. R., Ho, C. Y., Asif, I. M., Balaji, S., Burke, M. A., Day, S. M., Dearani, J. A., Epps, K., Evanovich, L., Ferrari, V. A., et al. (2024) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2024.02.014 · Cited by 425